A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
Clinical trial NCT05182931 · UNKNOWN
Trial details
- NCT number
- NCT05182931
- Sponsor
- Olivia Newton-John Cancer Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2024-12-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.